In a new job - March 26, 2015
Mendor Names Medical Director
Diabetes researcher Dr. Antonio Ceriello has been named medical director of Finnish company Mendor. Currently Professor Ceriello is head of the Research Department on Diabetes and CVD at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and is the president of the European Association for the Study of Diabetes Study Group on […]
Collaboration - March 25, 2015
Denator, M4I to Collaborate
Denator AB has entered a two-year collaboration with the Maastricht MultiModal Molecular Imaging Institute (M4I) of Maastricht University, the Netherlands. As part of the collaboration, Denator will work closely with the M4I Division of Imaging Mass Spectrometry, headed by university professor Ron Heeren, to jointly develop and evaluate innovative sample stabilization approaches for clinical applications, […]
Funding - March 25, 2015
Janssen Joins Dementia Project
Johnson & Johnson’s Janssen Pharmaceutical Companies plan to invest $10 million in a new UK government-led global dementia discovery fund for research to find ways to prevent and treat dementia and Alzheimer’s disease. The investment will come through its affiliate venture arm, Johnson & Johnson Innovation – JJDC, Inc. The global Dementia Discovery Fund brings […]
Acquisition - March 25, 2015
Novo Sells Autoimmune Program
Novo Nordisk has sold one of its early-stage autoimmune research programs to Bristol-Myers Squibb for an undisclosed amount. As part of the agreement, Bristol-Myers obtains the exclusive rights to a discovery-stage biologics program that targets the innate immune system, which is the body’s first line of defense against infection. Novo’s program was striving to treat […]
Acquisition - March 24, 2015
AZ Adopts e-Commerce Platform
Assay Depot, Inc., in conjunction with Astra Zeneca, recently developed and launched a preclinical research e-commerce platform called the AstraZeneca Innovation Marketplace (AIM). The program helps accelerate research and shorten the research cycle by automating legal and administrative processes. “AIM simplifies the purchase of preclinical services from our external partners. It will make our researchers’ […]
Acquisition - March 24, 2015
Skavak Buys Nordic Nanovector Shares
Skavak Invest AS, a company controlled by a close associate of Tone Kvåle, who is the chief financial officer of Nordic Nanovector ASA, purchased 3,000 shares in Nordic Nanovector ASA at an average share price of NOK 35 per share. Following the transaction and completion of the offering, Tone Kvåle will own 38,292 shares and […]
